Neurocrine Biosciences Inc
Open
SectorHealthcare
168.49 2.79
Overview
Share price change
24h
Min
163.24
Max
169.31
Income | 44M 198M |
|---|---|
Sales | 9M 815M |
P/E Sector Avg | 24.903 50.958 |
EPS | 1.94 |
Profit margin | 24.297 |
Employees | 2,000 |
EBITDA | 19M 254M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +12.91% upside |
Next Earnings | 29 Jul 2026 |
|---|
Market Cap | 2.8B 16B |
|---|---|
Previous open | 165.7 |
Previous close | 168.49 |
News Sentiment
By Acuity
13%
87%
20 / 342 Healthcare
Neurocrine Biosciences Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Neurocrine Biosciences Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 190.27 USD 12.91%
High 246 USD
Low 144 USD
Based on 24 Wall Street analysts offering 12 month price targets forNeurocrine Biosciences Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$